bims-placeb Biomed News
on Placental cell biology
Issue of 2026–11–08
eleven papers selected by
Carlos M Guardia, National Institute of Environmental Health Sciences



  1. Life Sci Alliance. 2027 Jan;pii: e202603923. [Epub ahead of print]10(1):
      Transposable elements (TEs) have made important contributions to the evolution of the placenta, being co-opted to form key placental genes, as well as trophoblast-specific gene regulatory elements. But although multiple TE subfamilies have been shown to act as transcriptional enhancers in early mouse trophoblast development, it remains unclear to what extent TEs regulate placental gene expression after the establishment of a functional foetal-maternal interface. Here, we characterised the TE regulatory and transcriptional landscape in mouse placenta and gauged their evolutionary dynamics. We found that the overall gene regulatory potential of TEs is greatly diminished in differentiated mouse trophoblasts when compared to their stem cell counterpart. However, evolutionarily young intracisternal A-particle elements are highly expressed in the placenta and create several alternative, placenta-specific transcriptional start sites for protein-coding genes. Intracisternal A-particle elements that are active in the placenta drive species-specific expression of associated genes and display wide genetic diversity between mouse strains. These putative co-option events are therefore evolutionarily recent and may represent a prime example of how TE activity can drive fast placental evolution.
    DOI:  https://doi.org/10.26508/lsa.202603923
  2. Pharmacol Res. 2026 Nov 03. pii: S1043-6618(26)01645-2. [Epub ahead of print]234 109730
      Preeclampsia (PE) is a severe pregnancy disorder characterized by hypertension and multi-organ dysfunction. Impaired trophoblast function and defective spiral artery remodeling are considered the central pathological features of PE, leading to placental ischemia/hypoxia and a subsequent inflammatory cascade. Increasing evidence has demonstrated that pyroptosis contributes to placental dysfunction and the establishment of a pro-inflammatory microenvironment in PE; however, the mechanisms remain largely unclear. O-linked β-N-acetylglucosamine (O-GlcNAc) modification is a reversible post-translational modification (PTM) that plays critical roles in maintaining cellular homeostasis and regulating multiple forms of programmed cell death (PCD), yet its role in pyroptosis during PE has not been elucidated. In the present study, we found that O-GlcNAcylation was markedly reduced in placental tissues from patients with PE and negatively correlated with pyroptosis. In both an LPS-induced PE-like mouse model and trophoblast cells, enhancement of O-GlcNAcylation significantly suppressed pyroptosis and ameliorated PE-like phenotypes. IP-MS identified UBAP2L as a critical O-GlcNAcylated protein. Mechanistically, T446, an O-GlcNAcylation site of UBAP2L, contributed to maintaining its protein stability by preventing ubiquitin-mediated proteasomal degradation and promoted its interaction with DDX21, thereby promoting stress granule formation. This process suppressed inflammasome activation and pyroptosis, improved trophoblast function, and ameliorated PE-like phenotypes. Collectively, our findings define an O-GlcNAcylation-UBAP2L-DDX21-stress granule-pyroptosis axis in PE and nominate O-GlcNAc signaling as a therapeutic target.
    Keywords:  DDX21; O-GlcNAcylation; Preeclampsia; Pyroptosis; Stress granule; UBAP2L
    DOI:  https://doi.org/10.1016/j.phrs.2026.109730
  3. Cell Rep. 2026 Oct 30. pii: S2211-1247(26)01290-8. [Epub ahead of print]45(11): 118211
      Preeclampsia (PE) is characterized by insufficient extravillous trophoblast (EVT) invasion, but the cytoskeletal mechanisms restraining EVT motility remain unclear. TMT-based placental proteomics identified the cytoskeletal adaptor PDLIM1 as markedly upregulated in PE. In primary trophoblasts and cell lines, PDLIM1 depletion remodeled the actin cytoskeleton and enhanced migration and invasion, whereas trophoblast-restricted Pdlim1 overexpression impaired trophoblast invasion and placental development in mice. Mechanistically, PDLIM1 bounds the rod domain of α-actinin-4 (ACTN4) and competitively displaced USP14, limiting ACTN4 deubiquitination and shifting ACTN4 toward RNF38-associated K48-linked ubiquitination and proteasomal turnover. Importantly, placenta-targeted chondroitin sulfate A-binding nanoparticles delivering Pdlim1 short hairpin RNA (shRNA) alleviated PE-like maternal and fetal phenotypes in mice. Collectively, these findings define a PDLIM1-USP14-ACTN4 proteostatic axis controlling trophoblast invasive homeostasis and identify PDLIM1 as a potential therapeutic target in PE.
    Keywords:  CP: cell biology; CP: developmental biology; cytoskeleton; invasive homeostasis; nanoparticle; preeclampsia; ubiquitination
    DOI:  https://doi.org/10.1016/j.celrep.2026.118211
  4. Mol Ecol. 2026 Nov;pii: e70612. [Epub ahead of print]35(21):
      Environmental hypoxia at high elevations is linked to increased rates of gestational complications. Evolutionary adaptation to high elevation environments mitigates these complications across mammals, in part through changes in placental function that shape foetal growth potential in late pregnancy. To investigate the developmental origins of placental adaptation to hypoxia, we acclimated pregnant deer mice (Peromyscus maniculatus) derived from low- and high-elevation populations to normoxia or hypoxia (equivalent to 4300 m) and characterized the structure and transcriptome of foetal placentas. We show that gestational hypoxia induced remodelling of the placental transcriptome in susceptible, lowland-derived mice, but not in highland-derived mice. A subset of this transcriptional plasticity displayed genetic assimilation, in which highland placentas expressed the induced value observed in lowlanders. However, we also found evidence that highland-derived mice reversed some of the ancestral lowland responses to hypoxia. Specifically, gestational hypoxia tended to suppress metabolic pathways in the placentas of lowland mice, whereas these responses were attenuated in highland mice. This divergence was centred on mitochondrial metabolic pathways. More broadly, we show that both constitutive population-level differences and remodelling of ancestral plasticity in the placenta tune expression within a stable transcriptional network architecture. Our results point to the developing placenta's metabolic responses to hypoxia as an early and developmentally specific functional target that likely contributes to pathologies associated with gestational hypoxia in humans and other mammals.
    Keywords:  gene expression; high altitude; hypoxia; pregnancy
    DOI:  https://doi.org/10.1111/mec.70612
  5. Front Physiol. 2026 ;17 1963994
      Placental insufficiency is usually identified indirectly-through the maternal syndrome, the growth restriction it causes or lesions found after delivery. None of these defines the placenta's oxygen-transfer function, and each can be absent while fetal support is already inadequate. We propose that this function is relational: it should be defined by the balance between the fetal oxygen requirement, C o(t), and the effective capacity of the integrated maternal-placental-fetal chain to supply oxygen, O s(t), assessed at the fetal receiving end. Their difference, Δ(t) = C o(t) - O s(t), is a latent state rather than a measurable quantity; a positive imbalance denotes insufficiency of the integrated transfer relation and does not by itself identify the limiting component or imply intrinsic placental pathology, which a separate aetiological step must establish. Insufficiency is reached by supply-driven, demand-driven or, most commonly, mixed trajectories-the demand-driven route arising without a previously detectable placental abnormality. We distinguish this latent imbalance from placental signalling, which may reflect or mediate it but is not identical to it, and from its host-dependent clinical expressions. For placental growth factor (PlGF), we advance a falsifiable hypothesis: under a sustained positive imbalance, the highly oxidative placenta may shift towards oxygen-sparing metabolism, and the associated hypoxia-responsive and integrated stress-response signalling may lower PlGF, so that a gestational-age-inappropriate PlGF decline behaves as a delayed signal of sustained mismatch rather than a direct measure of fetal demand. Because the maternal syndrome is a host-dependent expression of the same signalling, its severity is only incompletely coupled to the fetal consequence, and fetal compromise can occur during relative maternal silence. We therefore argue that the reference endpoint for placental oxygen-transfer function should shift from the maternal syndrome to the adequacy of fetal support, with maternal and fetal morbidity remaining co-equal outcomes. The framework yields predictions on biomarker trajectories and maternal-fetal divergence, and explicit, multi-level conditions under which it would fail.
    Keywords:  fetal compromise; fetal growth restriction; fetal oxygen demand; maternoplacental supply; placental growth factor (PIGF); placental insufficiency; pre-eclampsia; reference endpoint
    DOI:  https://doi.org/10.3389/fphys.2026.1963994
  6. Placenta. 2026 Nov 04. pii: S0143-4004(26)00738-1. [Epub ahead of print]186 265-278
       INTRODUCTION: Illicit fentanyl exposure during pregnancy is associated with adverse outcomes. Yet its direct effects and their underlying molecular mechanisms in human trophoblasts remain largely unknown. Xylazine and medetomidine, two ɑ2-adrenergic agonists, were recently detected as adulterants in illicit fentanyl-containing products, and have been linked to worsened clinical outcomes.
    METHODS: We assessed the transcriptional responses of human trophoblast stem (TS) cells in their cytotrophoblast state (TS-CTBs) and derived syncytiotrophoblasts (STBs) after 4-day and 9-day exposure to fentanyl alone or combined with medetomidine and xylazine (FMX).
    RESULTS: Fentanyl alone produced modest gene expression changes in TS-CTBs, but consistently induced suppression of mitochondrial and ribosomal transcriptional programs in STBs regardless of exposure duration, an effect absent in parental TS-CTBs. 9-day FMX co-exposure influenced mitochondrial respiratory chain gene expression in derived STBs, resulting in discordant regulation of nuclear versus mitochondrial genome-encoded respiratory chain genes. Temporal pathway analysis reveals progressive trophoblast remodeling and dysregulation of mitochondrial transcriptional programs following fentanyl and FMX co-exposure.
    DISCUSSION: Together, these findings illuminate trophoblast pathways affected by fentanyl alone and by FMX co-exposure, and establish a basis for future studies examining the functional and clinical relevance of these transcriptional responses.
    Keywords:  Fentanyl; Medetomidine; Opioids; Transcriptomes; Trophoblast; Xylazine
    DOI:  https://doi.org/10.1016/j.placenta.2026.11.002
  7. Stem Cell Res. 2026 Oct 30. pii: S1873-5061(26)00221-7. [Epub ahead of print]97 104125
      Here we show that copy number variations seen in mouse trophoblast giant cells (TGCs) are recapitulated in cells differentiated into extraembryonic lineages directly from mouse embryonic stem cells (ESCs) by conditional repression of Oct4. These TGC-like cells in vitro are obtained after 15 days of differentiation induction as non-proliferating cells and are easily distinguishable from other cell types in a heterogeneous population by their large, flattened morphology. Through whole-genome amplification followed by next-generation sequencing (NGS) from selected individual single cells, copy number variations can be visualized along chromosomes in each TGC-like cell. We found that the copy number landscape is highly conserved across individual TGC-like cells and is reminiscent of the in vivo situation seen in TGCs. The observed over- and under-replicated genomic regions are largely consistent with early and late replicating regions of parental cells before differentiation. Previously identified underrepresented (UR) domains, which are particularly resistant to endoreplication activity, have been shown to replicate very late, even among the late-replicating regions. Our study demonstrated that the direct differentiation system provides a novel platform to study the mechanism underlying copy number regulation in TGCs.
    Keywords:  Copy-number variation; Endoreplication; Replication timing; TGC-like cells
    DOI:  https://doi.org/10.1016/j.scr.2026.104125
  8. Br J Clin Pharmacol. 2026 Nov 06.
       AIMS: Nirmatrelvir is an effective therapeutic option for COVID-19 infection and is often administered after symptom onset in pregnant individuals, but few data are available on the associated fetal exposure. The placental perfusion model evaluates maternal-fetal drug transfer across the human placenta and thus can determine fetal drug exposure. The objective of our study was to quantify the amount of nirmatrelvir transfer across the human placenta using the ex vivo placental perfusion model.
    METHODS: In a dual closed-closed perfusion of a single human placenta lobule, nirmatrelvir was added to the maternal circulation at its clinical concentration (2.21 μg/mL) or at 10 times this level (22.1 μg/mL). For each placenta studied, there was a 1-h perfusion control period followed by a 3-h exposure period. Samples of the perfusate were collected throughout the experiment to measure nirmatrelvir concentrations and placental viability markers.
    RESULTS: Perfusions conducted with nirmatrelvir at 2.21 μg/mL (n = 4) and 22.1 μg/mL (n = 5) concentrations showed a fetal-maternal concentration ratio (F:M) of 0.34 and 0.42, respectively, at 180 min. F:M was adjusted for nonplacental physiological factors, including binding of albumin and α-1-acid glycoprotein, and ionization. The adjusted F:M ranged from 0.26 to 0.35 for placentas perfused with 2.21 μg/mL and from 0.33 to 0.47 for placentas perfused with 22.1 μg/mL of nirmatrelvir.
    CONCLUSIONS: Nirmatrelvir readily crosses the term human placenta in a concentration-dependent manner. These transfer kinetics provide a foundation for future physiologically based pharmacokinetic modelling, supporting the development of personalized nirmatrelvir dosing strategies in pregnancy.
    Keywords:  COVID‐19; nirmatrelvir; pharmacokinetics; placental transfer; protease inhibitor
    DOI:  https://doi.org/10.1002/bcp.70887
  9. Theriogenology. 2026 Nov 02. pii: S0093-691X(26)00492-9. [Epub ahead of print]269 118302
      Estradiol (E2) is a key regulator of early conceptus development and trophoblast function in several placental mammals, including pigs. However, the molecular mechanisms underlying its action remain incompletely understood. This study investigated the effects of E2 on gene expression in porcine trophoblast cells, focusing on cell adhesion, invasion, proliferation, angiogenesis, and epigenetic regulation. We also examined the involvement of estrogen receptor (ESR) signaling in these responses. Developmental profiling of conceptus and trophoblast revealed dynamic changes in the expression of ITGAV, MUC4, STAT3, S100A9, and the epigenetic regulators DNMT3A and DNMT3B between days 10 and 25 of pregnancy, whereas DNMT1 expression remained stable. E2 selectively upregulated DNMT3A and DNMT3B expression without affecting DNMT1 expression. E2 also significantly modulated the expression of genes associated with trophoblast adhesion, invasion, proliferation, cytokine-mediated communication, and angiogenesis. These effects were largely abolished by the ESR antagonist (ICI 182,780), supporting ESR-mediated regulation. Ingenuity Pathway Analysis (IPA) suggested coordinated regulation of gene networks related to cell adhesion, migration, invasion, cytoskeletal organization, cell differentiation, proliferation, angiogenesis, inflammatory responses, prostaglandin and steroid metabolism, and hypoxia signaling. In conclusion, E2 orchestrates ESR-dependent transcriptional networks governing key trophoblast functions and regulates the expression of components of the de novo DNA methylation machinery in the porcine trophoblast during early pregnancy.
    Keywords:  Angiogenesis; Cell adhesion; Embryonic signal; Epigenetic regulation; Estradiol-17β; Implantation; Pregnancy
    DOI:  https://doi.org/10.1016/j.theriogenology.2026.118302
  10. Nat Cell Biol. 2026 Nov 03.
      Differential Hippo-LATS-YAP signalling controls the first mammalian cell-fate decision, yet how human trophectoderm specification progresses to chorion formation remains unknown. Here we establish a developmentally informed model in which LATS kinase inhibition initiates the trophectoderm trajectory without exogenous morphogens. Stage matching to an integrated embryo-chorion single-cell reference revealed ordered progression from early trophectoderm to secondary chorionic lineages. Whole-genome bisulfite sequencing showed a naive-like hypomethylated state followed by remethylation, with key known placenta-associated imprinted domains retaining methylation and allelic bias. We then established a three-dimensional human chorion model by agitating induced-cell aggregates in suspension, yielding secondary chorionic lineages that self-organized with outward-facing trophoblast polarity and inside-out stromal-epithelial topology. Endogenous WNT signalling was dispensable for initial trophectoderm induction but regulated later chorionic lineage balance. Isolating CLDN6+ITGA6- cells identified a proEVT-like intermediate with villous and extravillous potential. Together, this framework connects human trophectoderm induction to three-dimensional chorion modelling and enables investigation of placental specification.
    DOI:  https://doi.org/10.1038/s41556-026-02082-9
  11. Sci China Life Sci. 2026 Oct 30.
      β-Catenin/CTNNB1 is the key intracellular effector of the canonical Wnt signaling. While zygotic CTNNB1 is essential for gastrulation in mouse embryos, maternal CTNNB1 is thought to be dispensable for development to the blastocyst stage. Besides, it remains controversial whether maternal CTNNB1 is activated during preimplantation stages. In this study, we report that maternal CTNNB1 is required for activating canonical Wnt signaling after fertilization and sustaining robust blastocyst formation. Loss of maternal CTNNB1 causes developmental delay, impaired compaction, reduced trophectoderm (TE) cell number, and developmental defects at E18.5. Transcriptome profiling highlights widespread dysregulation of cell-cycle, MAPK/ERK, and apoptosis pathways. Treatment with basic fibroblast growth factor (bFGF) or overexpression of Ctnnb1, Erk2, or Ccnd1 can partially rescue preimplantation defects in maternal Ctnnb1 (MCtnnb1) mutant embryos. Mechanistically, maternal CTNNB1 promotes nuclear accumulation of phosphorylated ERK1/2 (pERK1/2) and transcription of Ccnd1 to sustain TE proliferation and robust blastocyst formation. Taken together, our findings shed light on the role of maternal CTNNB1 signaling in supporting preimplantation embryo quality in mammals.
    Keywords:   Ccnd1 ; CTNNB1; MAPK/ERK; Wnt signaling; embryo; mouse; preimplantation
    DOI:  https://doi.org/10.1007/s11427-026-3470-5